SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 197 filers reported holding SANGAMO THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.77 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $184,878 | +20.8% | 308,233 | +161.7% | 0.00% | – |
| Q2 2023 | $153,098 | -43.1% | 117,768 | -23.0% | 0.00% | -100.0% |
| Q1 2023 | $269,183 | -50.2% | 152,945 | -11.2% | 0.00% | 0.0% |
| Q4 2022 | $540,548 | -60.4% | 172,149 | -38.2% | 0.00% | -66.7% |
| Q3 2022 | $1,365,000 | +31.2% | 278,487 | +10.9% | 0.00% | +50.0% |
| Q2 2022 | $1,040,000 | -20.2% | 251,149 | +11.9% | 0.00% | +100.0% |
| Q1 2022 | $1,304,000 | -27.6% | 224,515 | -6.5% | 0.00% | 0.0% |
| Q4 2021 | $1,801,000 | -18.9% | 240,158 | -2.6% | 0.00% | -50.0% |
| Q3 2021 | $2,221,000 | +9.1% | 246,545 | +45.0% | 0.00% | 0.0% |
| Q2 2021 | $2,035,000 | -39.7% | 170,041 | -36.9% | 0.00% | -60.0% |
| Q1 2021 | $3,375,000 | -22.4% | 269,362 | -3.3% | 0.01% | -37.5% |
| Q4 2020 | $4,348,000 | +300.7% | 278,644 | +142.8% | 0.01% | +166.7% |
| Q3 2020 | $1,085,000 | -19.0% | 114,769 | -23.3% | 0.00% | -50.0% |
| Q2 2020 | $1,340,000 | +43.8% | 149,564 | +2.3% | 0.01% | -25.0% |
| Q1 2020 | $932,000 | -12.0% | 146,269 | +15.7% | 0.01% | +14.3% |
| Q4 2019 | $1,059,000 | +33.7% | 126,469 | +44.5% | 0.01% | +16.7% |
| Q3 2019 | $792,000 | +19.8% | 87,539 | +42.6% | 0.01% | 0.0% |
| Q2 2019 | $661,000 | +781.3% | 61,385 | +680.3% | 0.01% | +500.0% |
| Q1 2019 | $75,000 | -97.2% | 7,867 | -95.0% | 0.00% | -95.2% |
| Q3 2018 | $2,657,000 | +113.8% | 156,777 | +79.2% | 0.02% | +90.9% |
| Q2 2018 | $1,243,000 | -23.0% | 87,505 | +2.9% | 0.01% | -31.2% |
| Q1 2018 | $1,615,000 | -59.3% | 85,003 | -64.8% | 0.02% | -42.9% |
| Q4 2017 | $3,964,000 | +20.6% | 241,729 | +10.3% | 0.03% | -6.7% |
| Q3 2017 | $3,287,000 | +58.3% | 219,157 | -7.1% | 0.03% | +36.4% |
| Q2 2017 | $2,076,000 | +244.9% | 235,958 | +103.7% | 0.02% | +214.3% |
| Q1 2017 | $602,000 | +4.7% | 115,815 | -38.6% | 0.01% | +16.7% |
| Q4 2016 | $575,000 | -11.9% | 188,580 | +33.7% | 0.01% | -14.3% |
| Q3 2016 | $653,000 | -22.2% | 141,087 | -2.7% | 0.01% | -30.0% |
| Q2 2016 | $839,000 | -1.2% | 144,935 | +3.2% | 0.01% | -16.7% |
| Q1 2016 | $849,000 | +227.8% | 140,373 | +394.8% | 0.01% | +300.0% |
| Q4 2015 | $259,000 | -31.8% | 28,370 | -57.9% | 0.00% | -40.0% |
| Q3 2015 | $380,000 | -43.4% | 67,365 | +11.3% | 0.01% | -44.4% |
| Q2 2015 | $671,000 | -56.5% | 60,527 | -38.5% | 0.01% | -62.5% |
| Q1 2015 | $1,544,000 | -34.6% | 98,471 | -36.5% | 0.02% | -33.3% |
| Q4 2014 | $2,360,000 | +25.2% | 155,129 | -11.2% | 0.04% | +24.1% |
| Q3 2014 | $1,885,000 | -4.0% | 174,789 | +35.9% | 0.03% | -3.3% |
| Q2 2014 | $1,964,000 | +112.3% | 128,612 | +151.3% | 0.03% | +87.5% |
| Q1 2014 | $925,000 | +725.9% | 51,178 | +534.8% | 0.02% | +700.0% |
| Q4 2013 | $112,000 | -43.4% | 8,062 | -68.2% | 0.00% | -60.0% |
| Q2 2013 | $198,000 | – | 25,341 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Golden State Equity Partners | 154,360 | $897,000 | 0.45% |
| Rhenman & Partners Asset Management AB | 761,429 | $4,424,000 | 0.44% |
| Lombard Odier Asset Management (Switzerland) SA | 860,702 | $5,001,000 | 0.39% |
| WASATCH ADVISORS LP | 10,576,997 | $61,452,000 | 0.30% |
| Rokos Capital Management LLP | 977,663 | $5,861,000 | 0.27% |
| KLK CAPITAL MANAGEMENT LLC | 44,323 | $258,000 | 0.26% |
| Long Focus Capital Management, LLC | 340,000 | $1,975,000 | 0.25% |
| Vanguard Capital Wealth Advisors | 33,380 | $193,000 | 0.14% |
| Fort Sheridan Advisors LLC | 73,978 | $430,000 | 0.13% |
| Delphia (USA) Inc. | 20,983 | $122,000 | 0.09% |